Orgenesis awarded EUR 2M grant from Walloon Government in Belgium

Orgenesis announced that the Company’s consortium was awarded a EUR 2.0M grant from the Walloon Government in Belgium, titled: “Monitoring with AI of Decentralized ATMP Manufacturing”. The consortium members include: Orgenesis Services Belgium, Universite catholique de Louvain / TRusted AI Labs and DNAlytics. Advanced Therapy Medicinal Products are among the most innovative and promising biomedicines designed to address unmet medical needs, including cell, gene, exosome and phage therapies. On January 17, 2024, the Walloon government launched a partnership, ATMP-Partenariat d’Innovation Technologique, with an EUR 81 million budget over three years, dedicated to ATMPs, in collaboration with BioWin, the health cluster for Wallonia, and the Public Service of Wallonia. The MAIDAM project is focused on developing AI-based approaches for the monitoring and improvement of decentralized manufacturing processes for ATMPs via federated machine and reinforcement learning utilizing cell therapy processing on small and standardized manufacturing units.